Sangamo Therapeutics, Inc. (SGMOQ)
0.1662
0.00 (0.00%)
USD |
OTCM |
Sep 03, 16:00
Sangamo Therapeutics Cash and Short Term Investments (Quarterly) : 27.59M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 27.59M |
| December 31, 2025 | 20.95M |
| September 30, 2025 | 30.53M |
| June 30, 2025 | 38.34M |
| March 31, 2025 | 25.18M |
| December 31, 2024 | 41.92M |
| September 30, 2024 | 39.20M |
| June 30, 2024 | 27.79M |
| March 31, 2024 | 55.33M |
| December 31, 2023 | 81.00M |
| September 30, 2023 | 132.11M |
| June 30, 2023 | 143.10M |
| March 31, 2023 | 205.39M |
| December 31, 2022 | 277.63M |
| September 30, 2022 | 313.57M |
| June 30, 2022 | 315.72M |
| March 31, 2022 | 317.80M |
| December 31, 2021 | 376.55M |
| September 30, 2021 | 423.41M |
| June 30, 2021 | 529.65M |
| March 31, 2021 | 587.08M |
| December 31, 2020 | 641.42M |
| September 30, 2020 | 648.83M |
| June 30, 2020 | 664.85M |
| March 31, 2020 | 358.13M |
| Date | Value |
|---|---|
| December 31, 2019 | 362.47M |
| September 30, 2019 | 356.85M |
| June 30, 2019 | 443.10M |
| March 31, 2019 | 351.00M |
| December 31, 2018 | 400.13M |
| September 30, 2018 | 458.57M |
| June 30, 2018 | 539.45M |
| March 31, 2018 | 229.53M |
| December 31, 2017 | 243.31M |
| September 30, 2017 | 236.70M |
| June 30, 2017 | 249.91M |
| March 31, 2017 | 129.27M |
| December 31, 2016 | 142.54M |
| September 30, 2016 | 145.58M |
| June 30, 2016 | 172.28M |
| March 31, 2016 | 187.58M |
| December 31, 2015 | 209.00M |
| September 30, 2015 | 219.33M |
| June 30, 2015 | 214.23M |
| March 31, 2015 | 196.22M |
| December 31, 2014 | 179.28M |
| September 30, 2014 | 162.74M |
| June 30, 2014 | 193.98M |
| March 31, 2014 | 213.75M |
| December 31, 2013 | 93.13M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Anixa Biosciences, Inc. | 13.69M |
| Vicapsys Life Sciences, Inc. | 0.1325M |